Dr. Arushi Manchand along with CPPR Faculty, Dr. Na Li and Dr. Robin Bogner published their findings on how elevated pH can slow the desupersaturation of a weak acid. To read more about the mechanism, click on https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.0c00539.
Author: Nault, Joanne
CPPR Student, Dana Moseson, awarded 2020 NIPTE Outstanding Student Researcher
Dana Moseson, Ph.D. candidate in Lynne Taylor’s group at Purdue University, and University of Minnesota student, Hongbo Chen from CPPR Faculty Calvin Sun’s group, were awarded the 2020 Outstanding Student Researcher by the National Institute for Pharmaceutical Technology and Education. Dana and Hongbo join graduated CPPR Student, Shreya Kulkarni (UConn), the 2019 winner and 2018 winner,
Nivedita Shetty (Purdue University) in receiving this prestigious award.
Nami Therapeutics Corporation Introduces CPPR Associate Director, Xiuling Lu, as CEO
CPPR faculty member and Associate Director has been announced as Nami Therapeutics CEO. While still an associate professor at UConn and on the leadership team of CPPR, Dr. Lu adds this new role to her portfolio. You can read more on LinkedIn or Twitter.
Learn more about CPPR Faculty, Raman Bahal, featured in UConn TODAY’s Meet the Researcher Column
Dr. Raman Bahal was featured in UConn TODAY’s Meet the Researcher column. To see what this promising new faculty member has been doing since joining UConn in 2017, click HERE
CPPR Project Report Included in JPharmSci Most Original and Most Significant Scientific Findings Virtual Issue
A recent paper authored by Dr. Rui Fang, UConn graduate now at Merck, describing her CPPR project findings was one of eight selected from the 70 papers in the second quarter of Journal of Pharmaceutical Science to be available in its Virtual Issue: Most Original and Most Significant Scientific Findings. CPPR Faculty at Purdue University, Dr. Greg Knipp, also has a paper in the same virtual issue. Read more at https://jpharmsci.org/most-original.
CPPR Project Explores Formulation Design for Inkjet-based 3D Tablets
CPPR Faculty, @BodhiChaudhuri, and his research team report on the formulation parameters required for printability of tablets using inkjet processing. They suggest several preformulation studies to assure printability and tablet performance. Read more at https://doi.org/10.1016/j.ijpharm.2020.119430. @KoyelSen, @ArushiManchanda, @TanuMehta, and @AnsonMa are co-authors on the @UConn Research publication.
CPPR Faculty Invents Nanoparticle for Overcoming Leukemia Treatment Resistance
UConn’s @XiulingLu developed nanoparticles used in study described in Nature Cell Biology which shows a successful strategy for overcoming anticancer therapy resistance. Read more here.
#uconnpharmacy
CPPR Project Yields New Model of Freeze Concentration of Protein Solutions
Recent graduate, Dr. Ji-Qin Lin, and her advisor, Professor Tai-Hsi @Fan Tai-Hsi, published their findings on their model of freezing dynamics in the International Journal of Heat and Mass Transfer. For an interesting read, follow https://doi.org/10.1016/j.ijheatmasstransfer.2020.119915.
Another @Kildsig CPPR Project Yields Results Available from J Pharm Sci free until July 9, 2020
CPPR student, @Rui Fang, now at Merck and her co-authors, @Robin Bogner, Steven Nail and the late Michael Pikal, published more of thefindings from her CPPR project. See the article “Stability of Freeze-Dried Protein Formulations: Contributions of Ice Nucleation Temperature and Residence Time in the Freeze-Concentrate”. Click on https://authors.elsevier.com/a/1b5id55Jf5M59 to see the full article.
CPPR Faculty promoted to Full Professor
The Board of Trustees of the University of Connecticut voted on April 29, 2020 to promote Kildsig CPPR Faculty, Bodhi Chaudhuri, to Full Professor effective August 23, 2020. Dr. Chaudhuri is best known for discrete element modeling (DEM) of many pharmaceutical processes. Recently, he has expanded his research group’s modeling expertise to modeling that couples DEM with computational fluid dynamics modeling, and artificial neural networks.